Risk of Melanoma in Patients With Congenital Melanocytic Nevi of All Sizes Journal of the European Academy of Dermatology and Venereology
TAKE-HOME MESSAGE
This systematic review and meta-analysis examined the literature on congenital melanocytic nevi (CMN) to determine the risk of melanoma development in these lesions. The overall incidence density was 0.057% person-years. In patients with small- or medium-sized CMN, the median age at melanoma onset was 22 years. Melanomas were typically cutaneous, located on the trunk, and associated with large or giant CMN.
- Dermatologists should be aware of the risks and features of melanoma development in patients with CMN.
This systemic review corroborates the previous findings that congenital melanocytic nevi (CMN) are known risk factors for early childhood development of melanoma, particularly in large and giant CMNs on axial body locations, especially on the trunk. Removal of large and giant CMNs is a therapeutic challenge. While the risk is not zero for medium CMNs, it is still relatively low risk and reassuring. Risk of melanoma for small CMNs could not be ascertained here, although previous studies have highlighted that a single small CMN also confers very low risk; multiple CMNs would increase the risk.1 It is beneficial to counsel all patients with CMNs (special emphasis and attention to those with projectedlarge/giant CMNs) and their family members on the ABCDEs of nevi/moles and sun-protective measures.
Reference
- Kinsler VA, O'Hare P, Bulstrode N, et al. Melanoma in congenital melanocytic naevi. Br J Dermatol. 2017;176(5):1131-1143. https://onlinelibrary.wiley.com/doi/10.1111/bjd.15301
Risk of melanoma in congenital melanocytic nevi of all sizes: a systematic review
J Eur Acad Dermatol Venereol 2022 Sep 23;[EPub Ahead of Print], C Scard, H Aubert, M Wargny, L Martin, S BarbarotSkin Care Physicians of Costa Rica
Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574
Please excuse the shortness of this message, as it has been sent from
a mobile device.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home